Trial intelligence / Profile preview

Surgical vs Pharmacological Treatment for PDA in Preterm Infants

NCT02602054Phase 2Unknown

Sponsor
Hospital General Naval de Alta Especialidad - Escuela Médico Naval
Start
Oct 2015
Primary completion
Apr 2016
Countries
1
01

Overview

Phase 2, randomised, open-label trial (2 arms), sponsored by Hospital General Naval de Alta Especialidad - Escuela Médico Naval. Primary endpoint: Success rate of closure patent ductus arteriosus. Status: unknown.

Beyond the preview

Go deeper on NCT02602054.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02602054.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call